19-35527027-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001166034.2(SBSN):āc.1255G>Cā(p.Ala419Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000035 in 1,541,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A419S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001166034.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SBSN | NM_001166034.2 | c.1255G>C | p.Ala419Pro | missense_variant | 1/4 | ENST00000452271.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SBSN | ENST00000452271.7 | c.1255G>C | p.Ala419Pro | missense_variant | 1/4 | 1 | NM_001166034.2 | P2 | |
SBSN | ENST00000518157.1 | c.376-150G>C | intron_variant | 1 | A2 | ||||
SBSN | ENST00000588674.5 | c.315+880G>C | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152056Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000269 AC: 4AN: 148724Hom.: 0 AF XY: 0.0000380 AC XY: 3AN XY: 79046
GnomAD4 exome AF: 0.0000374 AC: 52AN: 1389710Hom.: 0 Cov.: 64 AF XY: 0.0000423 AC XY: 29AN XY: 685742
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2024 | The c.1255G>C (p.A419P) alteration is located in exon 1 (coding exon 1) of the SBSN gene. This alteration results from a G to C substitution at nucleotide position 1255, causing the alanine (A) at amino acid position 419 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at